Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairAnti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safetyFibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.Optic neuritis with concurrent etanercept and isoniazid therapy.
P2860
Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tumour necrosis factor and ant ...... of the central nervous system.
@ast
Tumour necrosis factor and ant ...... of the central nervous system.
@en
Tumour necrosis factor and ant ...... of the central nervous system.
@nl
type
label
Tumour necrosis factor and ant ...... of the central nervous system.
@ast
Tumour necrosis factor and ant ...... of the central nervous system.
@en
Tumour necrosis factor and ant ...... of the central nervous system.
@nl
prefLabel
Tumour necrosis factor and ant ...... of the central nervous system.
@ast
Tumour necrosis factor and ant ...... of the central nervous system.
@en
Tumour necrosis factor and ant ...... of the central nervous system.
@nl
P2860
P1476
Tumour necrosis factor and ant ...... of the central nervous system.
@en
P2093
K W Selmaj
P2860
P304
P356
10.1136/ARD.59.SUPPL_1.I94
P407
P478
59 Suppl 1
P577
2000-11-01T00:00:00Z